This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Read our cookie policy.
Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
President
Fresenius Renal Therapies Group
As president of Renal Therapies Group, Mark Costanzo oversees renal products and pharmaceutical operations, including sales, marketing, the Renal Research Institute, medical and regulatory affairs, and Mexico and Canada operations. He assumed this position in January 2010.
Mark joined Fresenius Medical Care in 1990 and has held several positions including vice president, Peritoneal Dialysis Products, and vice president, sales and marketing. He began his career in the renal industry more than thirty years ago with Baxter International.
© 2006-2020, Fresenius Medical Care, All Rights Reserved